Fasciolosis 2nd Edition PDF Book. Fasciolosis is a major global infection of livestock causing both huge losses to the agricultural community and affecting human health as a food-borne disease. Fully updated throughout, this new edition continues to cover the life cycle, biology, and development of the parasite; clinical pathology, immunology, diagnosis and vaccine development; and emergence, cause and mechanisms of drug resistance. It reviews the temperate liver fluke Fasciola hepatica, together with molecular, biochemical, control, and epidemiologial aspects of the tropical liver fluke F. gigantica.
Many fundamental advances have taken place in the last two decades, but of particular importance has been the mapping of the draft genome of Fasciola. In addition, comprehensive advances in transcriptomics, proteomics and glycomics have been made, and the Fasciolosis 2nd Edition book therefore pays particular attention to these developments with the addition of brand-new chapters. Also covering the impact these parasites have had on the global human population, their distribution and their ecology, Fasciolosis 2nd Edition provides a comprehensive and accessible resource for scientists, researchers and students of medical and veterinary parasitology.
1: The Discovery of Fasciola hepatica and its Life Cycle. STUART J. ANDREWS, KRYSTYNA CWIKLINSKI AND JOHN PIUS DALTON.
2: Fasciola hepatica larval development within the intermediate host. GILLES DREYFUSS, PHILIPPE SINDOU, PHILIPPE HOURDIN, PHILIPPE VIGNOLES AND DANIEL RONDELAUD.
3: Development of Fasciola hepatica in the Mammalian Host. MARK W. ROBINSON, ROBERT E.B. HANNA AND IAN FAIRWEATHER.
4: The Reproductive System of Fasciola hepatica. ROBERT E.B. HANNA, IAN FAIRWEATHER AND MARK W. ROBINSON.
5: Pathology, Pathophysiology and Clinical Aspects. NICHOLAS C. SANGSTER, ALVARO MARTÍNEZ-MORENO AND JOSÉ PÉREZ.
6: Epidemiology and Control. GABRIELA KNUBBEN-SCHWEIZER, ANNE-SOPHIE RÖSSLER, EVA SCHADE-WESKOTT AND PAUL R. TORGERSON.
7: Flukicidal Drugs: Pharmaco-therapeutics and Drug Resistance. LUIS I. ALVAREZ, CARLOS E. LANUSSE, DIANA J.L. WILLIAMS, IAN FAIRWEATHER AND JANE E. HODGKINSON.
8: Metabolism. ALOYSIUS G. M. TIELENS AND JAAP J. VAN HELLEMOND.
9: Immunological Interaction Between Fasciola and its Host. SHEILA DONNELLY, ROBIN FLYNN, GRACE MULCAHY AND SANDRA O’NEILL.
10: Diagnostics for Animal and Human Fasciolosis. FLORENCIO M. UBEIRA, VICTORIA MARTÍNEZ-SERNÁNDEZ, MARTA GONZÁLEZ-WARLETA, MERCEDES MEZO.
11: Applying ‘omics’ Technologies to Understand Fasciola spp. Biology. KRYSTYNA CWIKLINSKI, CAROLINA DE MARCO VERISSIMO, PAUL MCVEIGH, SHEILA DONNELLY AND JOHN P. DALTON.
12: Vaccines for Fasciola (liver fluke): New Thinking for an Old Problem. TERRY W SPITHILL, HAYLEY TOET, VIGNESH RATHINASAMY, GEMMA ZERNA, JACLYN SWAN, TIMOTHY CAMERON, PETER M SMOOKER, DAVID M PIEDRAFITA, ROBERT DEMPSTER, TRAVIS BEDDOE.
13: Fasciola gigantica and Fasciola-hybrids in Southeast Asia. NICHOLA CALVANI AND JAN ŠLAPETA.
14: Global Impact of Human Fascioliasis. PREETAM GANDHI, RICHA CHANDRA, ESTHER K. SCHMITT, CHIEN-WEI CHEN, SANJAY SAMANTRAY, VINAY KUMAR VENISHETTY, DAVID HUGHES.
